- European Union’s Horizon 2020 research and innovation program
EUROoC creates a trans-European network of application-oriented researchers fully trained in development and application of the emerging Organ-on-Chip (OoC) technology. The field of OoCs is advancing at breath taking pace due to its potential impact in drug development and personalized treatments of disease. New researchers entering this field must be equipped with a multidisciplinary background ranging from biology to microfluidic chip engineering.
EUROoC offers the first complete and coherent European training program on OoC by gathering participants from various disciplines (Biology, Engineering, Medicine, Physics, Chemistry) in a multi-sectoral network composed of 26 project partners (11 universities, 3 non-profit R&D institutes, 4 regulatory experts, 8 companies). EUROoC qualifies the next generation of interdisciplinary scientists for all aspects of OoC development and utilization, including understanding of commercialization pathways and regulatory aspects.
Jena University Hospital, Germany
Graz University of Technology, Austria
University of Bern, Switzerland
Uppsala University, Sweden
University of Twente, The Netherlands
Leiden University Medical Center (LUMC), The Netherlands
University of Luxembourg, Luxembourg
École Polytechnique Fédérale de Lausanne (EPFL), Switzerland
German Federal Institute for Risk Assessment (BfR), Germany
Miltenyi Biotec GmbH, Germany